Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 665

Results For "RI"

10348 News Found

Eni and Dompe farmaceutici join forces for health research
News | October 11, 2023

Eni and Dompe farmaceutici join forces for health research

Eni will guarantee Dompé researchers access to its laboratories, support from the company's specialized staff, and use of its HPC5 supercomputer


Mandaviya inaugurates new facilities at NIMHANS and launches new logo of Tele-MANAS
Healthcare | October 11, 2023

Mandaviya inaugurates new facilities at NIMHANS and launches new logo of Tele-MANAS

Tele-MANAS has counseled more than 3,50,000 people till date and currently provides counseling to 2000 people through 44 Tele Manas Cells


Philips and World Stroke Organization partner to improve access to high-quality stroke care
News | October 11, 2023

Philips and World Stroke Organization partner to improve access to high-quality stroke care

Two-year partnership focused on advocacy, education, and raising awareness of stroke as a global healthcare challenge


Astellas, BioLabs and Mitsui Fudosan collaborate to enhance life science ecosystems in Tsukuba and Kashiwa-no-ha, Japan
News | October 11, 2023

Astellas, BioLabs and Mitsui Fudosan collaborate to enhance life science ecosystems in Tsukuba and Kashiwa-no-ha, Japan

Astellas stands on the forefront of healthcare change to turn innovative science into value for patients


Sun Pharma gets USFDA filing acceptance of new drug application for Deuruxolitinib
Drug Approval | October 09, 2023

Sun Pharma gets USFDA filing acceptance of new drug application for Deuruxolitinib

The NDA filing for deuruxolitinib with the U.S. FDA is based on two pivotal Phase III trials


Mitsui invests in Lokavant Holdings
News | October 09, 2023

Mitsui invests in Lokavant Holdings

Lokavant provides clinical trial intelligence


Biocon Biologics gets complete response letter from USFDA for Biosimilar Insulin Aspart
Drug Approval | October 09, 2023

Biocon Biologics gets complete response letter from USFDA for Biosimilar Insulin Aspart

The company had submitted a comprehensive Corrective and Preventive Action (CAPA) plan in September 2022


Biocon signs commercialization agreement with Juno Pharmaceuticals in Canada
News | October 09, 2023

Biocon signs commercialization agreement with Juno Pharmaceuticals in Canada

Biocon will be responsible for obtaining regulatory approval for Liraglutide, and thereafter, for the manufacture and supply of the product in the Canadian market


Zydus receives final approval from the USFDA for Sugammadex Single-Dose Vial
Drug Approval | October 09, 2023

Zydus receives final approval from the USFDA for Sugammadex Single-Dose Vial

Sugammadex Injection is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide


India has taken a lead in Preventive and Integrated Healthcare, says Dr Jitendra Singh
Digitisation | October 09, 2023

India has taken a lead in Preventive and Integrated Healthcare, says Dr Jitendra Singh

Dr. Singh proposes upskilling medicos with AI, Quantum and other newer technologies to meet the changing requirements of patient care